🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#TumorBoardTuesday 👏It is amazing how many HER2🎯💊options there are for metastatic bladder cancer 📢Join us Tuesday, 10-29-24 at 8PM ET as Matt Galsky & Eric Miller, MD 🗣️the multitude of therapies for HER2+ Bladder Cancer RT and bring others into the discussion‼️

#PreTest Q1️⃣ #TumorBoardTuesday Free #CME integrityce.com/TBT2024 ➡️Before Matt Galsky & Eric Miller, MD🗣️the multitude of therapies for HER2+ Bladder Cancer 🤔Which of the following ADCs target🏹HER2❓

Matt Galsky Eric Miller, MD #PreTest Q2⃣#TumorBoardTuesday Free #CME ➡️Your patient with HER2+ mUC (🔬IHC 3+) progresses on adjuvant gem/cis and 1L nivolumab ➡️He then achieves partial response to disitamab vedotin before discontinuing for neuropathy 🧐Which would you select next❓